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doi:10.1016/j.ejvs.2009.03.009Abstract Background: Infected prosthetic grafts and mycotic aneurysms carry a high
mortality and morbidity rate, with a substantial risk of persistent graft infection, but there is
evidence that this can be minimised by using femoro-popliteal vein for arterial reconstruction
after debridement and graft excision. We present our 10-year experience of this technique.
Methods: Forty-six patients underwent 48 arterial reconstructions with femoro-popliteal vein
(24 aortic). Six had mycotic aneurysms (three aortic) and 40 had graft infections (16 aortic).
Results: There were two early postoperative deaths (4.3%) and two patients with pre-existing
ischaemia underwent major amputation despite a patent graft. Median follow-up was 4.1 years
(range: 2 months to 10 years). Patient survival was 70% and limb salvage 96% at 5 years. Primary
graft patency was 75% and 62% and secondary patency 93% and 91% at 2 and 5 years, respec-
tively. Two patients required further surgery for recurrent infection. Anastomotic or graft
stenosis occurred in 11 patients (24%). There were three major wound infections. Donor-limb
swelling was transient.
Conclusion: For arterial and prosthetic graft infections, femoro-popliteal vein is an excellent
conduit for vascular reconstruction after drainage and debridement of infected tissue and graft
material under antibiotic cover, providing good long-term survival and limb salvage.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Graft infections, especially those involving aortic recon-
structions, present a major problem in vascular surgery.
The incidence of graft infection following aortic723581; fax:þ441792723583.
om (C.P. Gibbons).
ty for Vascular Surgery. Publishereconstruction ranges from 0.7 to 2.0% and is associated
with a mortality of 10e25% and a limb loss of 10e25%.1e3
Mycotic aneurysms present a similar therapeutic prob-
lem.4e7 Local surgery has only a limited scope for local-
ised infection in high-risk cases as it rarely eradicates
infection entirely.3,7e9 More radical treatment with graft
excision and extra-anatomic bypass or in situ recon-
struction with antibiotic-bonded prostheses carries a high
re-infection rate of 10e25% with a reported mortality ofd by Elsevier Ltd. All rights reserved.
Femoral Vein in Vascular Infection 173about 25%.3,4,10,11 Other treatment options include the
use of autogenous tissue such as long saphenous vein or
superficial femoral artery,12,13 or arterial allografts.14
Arterial reconstruction using femoro-popliteal vein (FPV) for
aortic graft infection was first reported 15 years ago, but
there have been few large series published to date.15e22
We previously reported our early experience of autogenous
reconstruction using FPV for arterial and prosthetic graft
infections.15,16 Here we present our experience over
a 10-year period.
Patients and Methods
Data were collected prospectively on all patients under-
going arterial reconstructions with FPV in the presence of
infection by the senior author (between 1997 and 2008).
These comprised 46 patients (36 men and 10 women)
undergoing 48 arterial reconstructions with FPV. The mean
age was 67 years, with a range from 54 to 89 years. The
mean age for the patients with aortic graft infections or
mycotic aneurysms (68 years) was not significantly different
from those with infections at other sites (66 years). During
this period only one patient e an 84-year-old man under-
going repair of an anastomotic false aneurysm of an aortic
tube graft that was found to be poorly incorporated
but without any surrounding pus at surgery e underwentTable 1 The site of the prosthetic graft infection in 40 patient
Site of graft infection No.
Aortic 16
Aortic tube graft 3
Aorto-iliac graft 4
Aorto-bifemoral graft 9
Femoro-femoral 10
Femoro-femoral graft 10
Axillio-femoral 6
Axillo-bifemoralb 3
Axillo-unifemoral 3
Femoropopliteal 4
Common femoral graft 1
Profunda femoris graft 1
Common femoral Dacron patch 1
Popliteal vein graft infected false aneurysm 1
Ilio-femoral 3
Ilio-femoral graft 1
Ilio-femoral cross-over 2
Axillo-axillary 1
Axillo-axillary graft 1
a Remaining graft replaced with femoral vein 3 years later in one p
b One patient with an axillo-bifemoral graft was found at operationre-vascularisation using a prosthetic graft in the presence of
infection.
Graft Infections
Forty patients had post-surgical graft infections, occurring
between 12 days and 28 years (mean: 58 months) (Table 1).
Of these, 39 were prosthetic graft infections and one was
an infected popliteal vein graft following an exclusion
bypass of a popliteal aneurysm. The modes of presentation
were: bleeding (four cases); false aneurysm (nine); sinus
with persistent discharge (eight); grafteenteric fistula
(two); occluded graft (two); abscess (two); and acute
ischaemia (one). The remaining graft infections were
discovered by the presence of perigraft fluid and/or gas on
ultrasound or computed tomography (CT) scan, preopera-
tive aspiration of pus or the discovery of pus around the
graft and the absence of graft incorporation at surgery.
Isotope-labelled leucocyte scans were not used.
In three cases, the infected axillo-bifemoral grafts were
excised and replaced with aorto-bifemoral FPV grafts. One
of these was also found to have an infected and occluded
aorto-iliac graft at operation.
One patient who underwent a common femoral vein
graft for an infected common femoral vein patch had
previously undergone an infra-renal aorto-superior mesenterics treated with femoro-popliteal vein grafts
Replacement procedure with FPV No.
Aorto-iliac bypass 2
Aorto-iliac þ right femoral jump graft 1
Aorto-iliac bypass 3
Aorto- right iliac þ left femoral bypass 1
Aorto-bifemoral bypass 7
Replacement one limb of aorto-bifemoral grafta 2
Femoro-femoral bypass 9
Ilio-femoral cross-over graft 1
Aorto-bifemoral bypass 3
Axillo-femoral bypass 1
Ilio-femoral bypass 2
Common femoral graft 1
Replacement of profunda jump graft 1
Common femoral tube graft 1
Popliteal vein graft 1
Femoro-femoral bypass 1
Ilio-femoral cross-over 2
Axillio-axillary bypass 1
atient.
to also have an infected occluded aorto-iliac graft.
174 O. Ehsan, C.P. Gibbonsartery graft using FPV together with a small bowel resection
for an ischaemic ileal perforation.
Mycotic aneurysms
Six patients had mycotic aneurysms: three involved the
infra-renal aorta, one the external iliac and two the
femoral artery. They presented with high fever, a pulsatile
mass, pain and leucocytosis. Confirmation of the diagnosis
was made by CT scan (loss of normal arterial wall with
perivascular inflammatory thickening), and digital
subtraction angiography (DSA) showing a localised saccular
aneurysm.
Bacteriology
An infecting organism was cultured in 33 cases (Table 2). Of
these, Staphylococcus aureus (including methicillin-resis-
tant S. aureus (MRSA)), Enterococcus and Escherichia coli
were the most common. In the remaining cases no organism
was cultured despite the presence of pus or a biofilm
around the graft and absence of graft incorporation.
Patient management
Preoperative investigations included intra-arterial DSA (for
all except those requiring emergency surgery for bleeding),
CT scan for mycotic aneurysms or aorto-iliac graft infection
and ultrasound for detection of fluid around extra-
anatomical grafts. Duplex imaging of the femoral and
popliteal veins was performed preoperatively to check their
patency and diameter.
Broad-spectrum antibiotics were given, both perioper-
atively (with specific antibiotics to cover any cultured
organism) and postoperatively. In cases where the respon-
sible organism was not known preoperatively, a combinationTable 2 Organisms cultured
Organism Number
Infected grafts
E. coli 6
Methicillin-resistant Staphylococcus aureus (MRSA) 4
Enterococcus 5
Staphylococcus aureus 1
Serratia 2
Staphylococcus epidermidis 2
Bacteroides 1
Corynebacterium 1
Pseudomonas 1
Coliform 1
Klebsiella 1
Candida 1
Mixed anaerobes 1
Mycotic aneurysms
Staphylococcus aureus 2
Methicillin-resistant Staphylococcus aureus (MRSA) 2
Streptococci 2
No growth 23of teicoplanin, co-amoxyclav, ciprofloxacin (or gentamicin)
and metronidazole was started immediately before surgery
and continued for 1 week, followed by co-amoxyclav for
a further 5 weeks. This was modified to cover any organism
grown preoperatively or from cultures taken at operation. In
four cases where partial or subtotal graft excision was
performed, low-dose antibiotic cover was continued indef-
initely (in most cases using co-amoxyclav). One of these
patients required complete replacement of the remaining
graft at a later date.
The operative procedure was the same as described in
our previous publications.15,16 For procedures requiring two
veins, both legs were prepared along with the appropriate
area of exposure for the bypass procedure. The FPV was
harvested from below the origin of the profunda femoris
vein to the knee joint, giving a 30e33-cm length of vein. A
single vein was adequate for aorto-iliac, ilio-femoral,
femoro-femoral or local common femoral grafts but veins
were required from both legs for aorto-bifemoral grafts or,
in one case, an axillo-femoral graft. Where possible, the
vein was harvested before entering the infected field. After
securing arterial control, the pus was drained, any infected
graft excised and the infected tissue was thoroughly
debrided (cutting back the infected artery to clean unin-
fected tissue) with repeated washouts with povidonee
iodine and hydrogen peroxide. The new bypass was then
constructed using continuous monofilament polypropylene
sutures. Where feasible, new grafts were tunnelled in a
clean field or wrapped in omentum. Gentamicin-
impregnated collagen foam was used to cover all anasto-
moses (except for gentamycin beads in one early case) prior
to closure. Multiple suction drains were used in all cases.Adjunctive procedures
Rectus femoris flaps were used in four patients and sarto-
rius flaps in another three where skin cover for the graft
was believed to be inadequate in the groin. Other adjunc-
tive procedures included femoro-popliteal bypass in two
and femoro-tibial bypass in one. One patient required an
immediate femoral embolectomy. Another, who presented
with an infected aortic tube graft communicating with
a pancreatic abscess, required a cystogastrostomy and
drainage of multiple intra-abdominal abscesses.23
Postoperative follow-up
Clinical follow-up and duplex Doppler graft surveillance
was performed routinely at 6 weeks, then 3-monthly for
1 year, 6-monthly for a further 2 years and yearly
thereafter.
Analysis
KaplaneMeier analysis of patient survival, limb salvage,
primary and secondary patency was performed using Systat
10 (SPSS Science Software UK Ltd, Birmingham, UK).
Comparisons of survival and graft patency for aortic and
non-aortic procedures were performed by log-rank test
(Mantel method) using the same computer program.
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Femoral Vein in Vascular Infection 175Results
Forty-six patients underwent 48 procedures with a mean
postoperative length of stay of 34 days (range: 6e181 days).
The mean follow-up was 4.7 years (range: 0e128 months).
Twenty-eight of these are continuing under regular follow-
up. Of the remaining 18 patients, two have been lost to
follow-up and 16 have died.
The operative morbidity and mortality are summarised
in Table 3.
Postoperative complications
One infarcted rectus femoris flap required removal. Six
patients developed seromas and three of these required
surgical drainage. One patient developed a left ureteric
leak following replacement of an infected aorto-bifemoral
graft with femoral vein. This was successfully treated
percutaneously by a ureteric stent and a temporary neph-
rostomy 4 days postoperatively. Another required lapa-
rotomy and adhesiolysis for intestinal obstruction.
Limb oedema
Transient donor-limb oedema occurred in all limbs from
which FPV had been harvested, but this usually settled
within 3 months. Severe donor-limb swelling with cuta-
neous bullae was seen in two patients but was managed
successfully with simple elevation. One patient also had
marked progressive donor-limb swelling over the first year
requiring the use of a compression stocking. Another
patient, who had undergone femoral vein bypass for a false
aneurysm of the external iliac artery, developed iliac vein
thrombosis on the side of the aneurysm. Another developed
mild lipodermatosclerosis at 1 year (becoming slightly
worse over the next 9 years) but none has developed
a varicose ulcer.
Recurrent or persistent infection
Three major groin-wound infections healed without
exposing the graft.Table 3 Operative mortality and morbidity
Early complications No. of patients
30-day postoperative mortality 2
Major amputation 2
Stenosis (anastomotic and graft limb) 11
Anastomotic false aneurysm 4
Major wound infection 3
Seroma 6
Severe donor-limb swelling 2
Graft thrombosis 0
Ureteric injury 1
Gastrointestinal bleeding 3
Myocardial infarction 2
Acute intestinal ischaemia 1
Adhesional obstruction 1
Renal failure (requiring long-term dialysis) 1Two patients had further graft or arterial infections: one
developed an infected false aneurysm above an aorto-iliac
vein graft 3 months after surgery for an aorto-duodenal
fistula, which was successfully treated by a further FPV
graft but required permanent dialysis after prolonged
suprarenal clamping. The other required further femoral
vein replacement of the residual graft limb 3 years after
partial replacement of an infected aorto-bifemoral graft to
eliminate the infection.
Mortality
There were two deaths within 30 days of surgery (4.3%):
one patient died in the recovery room from a myocardial
infarction after the replacement of a femoro-femoral
graft. The other died of distal small bowel and colonic
ischaemia 10 days after replacement of an infected aorto-
bifemoral graft. Further, another patient died at 38 days of
massive haematemesis giving an in-hospital mortality of
three (6.5%).
There were 14 deaths beyond 30 days at a mean of
4 years after the procedure. All of these had a patent graft,
except for two patients who died from acute aortic
thrombosis at 5 and 14 months after ilio-femoral cross-over
grafts with a femoral vein. (One of these, an 89-year-old
man, had undergone a normal duplex scan of the graft less
than 2 months earlier and had suffered a massive myocar-
dial infarction prior to the aortic thrombosis. The other,0 50 100 150
Time (months)
0.0
0.2
P
2yr Survival 84%
5yr Survival 70%
Time (months) 3 14 36 44 100 
Number at Risk 43 38 30 25 9 
KM Probability 0.93 0.87 0.79 0.70 0.57 
Standard Error 0.037 0.051 0.065 0.073 0.103
Figure 1 KaplaneMeier graphs for patient survival following
grafts with femoro-popliteal vein for infection (46 patients).
Each vertical line on the graph represents the last recorded
follow-up for a patient.
176 O. Ehsan, C.P. Gibbonsa 54-year-old man, a heavy smoker, with a previous aorto-
bifemoral graft had undergone a femoro-femoral graft for
an occluded graft limb 6 years later. The femoro-femoral
graft was replaced after a further 5 years with an
ilio-femoral FPV cross-over graft (from the patent aorto-
femoral graft limb) for infection. He failed to attend for
any graft scans or follow-up appointments over the next
14 months and presented with aortic thrombosis too late
for limb salvage). The 2- and 5-year patient-survival rates in
this series were 84 and 70%, respectively (Fig. 1).Limb salvage
Limb salvage was 96% at both 2 and 5 years (Fig. 2).Two
patients underwent major amputation: one presented with
an infected occluded axillo-femoral graft and an acutely
ischaemic foot. She underwent above-knee amputation at
3 days despite fasciotomy and a patent ilio-femoral bypass
with femoral vein. The other underwent amputation
through the hip joint at 43 days despite a patent
ilio-femoral vein graft. This patient had previously suffered
an unrecognised avulsion of the profunda femoris artery
during hip arthroplasty and presented 3 months later with
a mycotic aneurysm of the common femoral artery, a huge
abscess in thigh with extensive muscle necrosis and a septic
arthritis of the knee.0 50 100 150
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2yr limb salvage 96%
5yr limb salvage 96%
Time (months) 0.1 2.0
Number at risk 46 44
KM Probability 0.98 0.96
Standard Error 0.022 0.030
Figure 2 KaplaneMeier graphs for limb salvage following
grafts with femoro-popliteal vein for infection (46 patients).
Each vertical line on the graph represents the last recorded
follow-up for a patient.Graft patency
The commonest postoperative complication was anasto-
motic or graft-limb stenosis, which occurred in 11 patients
(24%) and was discovered by routine duplex surveillance:
five were at a proximal aortic anastomosis, two at a pro-
funda femoris anastomosis, two were stenoses of common
femoral anastomoses and two were inflow stenosis of
femoro-femoral cross-over grafts. Treatment of these
patients required secondary intervention in the form of
percutaneous transluminal angioplasty (PTA), open pro-
fundaplasty or a vein patch to the aortic anastomosis. Two
patients had graft-limb stenoses; one of which also had
a profunda stenosis and the other had an accompanying
aortic anastomotic stenosis. The former required PTA and
stenting but the latter responded to angioplasty alone. The
primary graft patency was 75% at 2 years and 62% at 5 years
(Fig. 3). The primary-assisted patency and secondary
patency were both 93% at 2 years and 91% at 5 years
(Fig. 4).
False aneurysms
Four patients developed anastomotic false aneurysms: in
one, an infected false aneurysm above an aorto-iliac vein
graft for an aorto-duodenal fistula was repaired with FPV
from the opposite leg at 3 months (as described above
under ‘‘Recurrent infection’’). In another, a femoral false0 50 100 150
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2yr Primary Patency 75%
5yr Primary Patency 62%
Time (months) 3 14 29 44 46 
Number at Risk 38 32 28 20 17 
KM Probability 0.82 0.77 0.70 0.66 0.62 
Standard Error 0.057 0.063 0.071 0.076 0.081 
Figure 3 KaplaneMeier graphs for primary graft patency
following grafts with femoro-popliteal vein for infection (46
patients). Each vertical line on the graph represents the last
recorded follow-up for a patient.
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5year Secondary Patency 91%
Time (months) 5 14 
Number at Risk 41 38 
KM Probability 0.93 0.91 
Standard Error 0.038 0.044 
Figure 4 KaplaneMeier graphs for secondary graft patency
following grafts with femoro-popliteal vein for infection (46
patients). Each vertical line on the graph represents the last
recorded follow-up for a patient.
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Standard Error 0.044 0.071 0.134 0.261
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Time (months) 3 14 36 100
Number at Risk 22 18 13 4
KM Probability 0.92 0.78 0.63 0.44
Standard Error 0.058 0.087 0.104 0.150
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Figure 5 KaplaneMeier analysis of patient survival for aortic
(22 patients) and non-aortic procedures (24 patients).
Comparison by log rank test (Mantel method).
Femoral Vein in Vascular Infection 177aneurysm required two subsequent repairs using arm veins,
followed by balloon angioplasty for restenosis. This patient
also developed a false aneurysm at the aortic anastomosis,
which was treated by relocating the anastomosis distally on
the aorta but subsequently required several percutaneous
angioplasties. In a third patient, a common femoral false
aneurysm was repaired surgically. In the fourth, a profunda
femoris false aneurysm was treated conservatively before
he died of myocardial infarction.
Aortic and non-aortic procedures
Comparison between aortic and non-aortic procedures
showed that survival was significantly better for aortic than
for non-aortic procedures, whereas graft patency was
similar (Figs. 5 and 6).
Discussion
FPV reconstruction has great advantages for graft infection
and mycotic aneurysms over the traditional approach of
graft excision with extra-anatomic or in situ bypass,21,24,25
which carries a mortality of approximately 20%, an ampu-
tation rate of 11%, a graft-failure rate approaching 35% and
between 10 and 23% re-infection rates.4,25e27 In contrast,
most series of FPV reconstruction for graft infection have
reported immediate postoperative or 30-day mortalities of
7.3e15.3%.17e20 In our series, the early (30-day) post-
operative mortality was 4.3%.The primary patency of FPV grafts has been reported to
be 83e91%, with secondary patencies of up to 100% at
5 years (range: 7.4 months to 10 years)17e21 and limb-
salvage rates of more than 85%.18e20 In the present series,
which is an update of our previously reported work,15 there
were no early graft thromboses although two patients
required amputation despite a patent graft. There were
two late graft thromboses, both presumably as a result of
atheromatous disease progression. Both of these patients
died without a major amputation, giving a secondary-
patency rate of 91% and a limb-salvage rate of 96% at
5 years.
The high rate of re-infection with synthetic grafts does
not appear to occur with FPV replacement in our series or
that of others,17,19,28 provided appropriate antibiotics are
administered and thorough debridement and antiseptic
washouts are performed. Placing the graft in a clean field,
omental wraps and coverage with muscle flaps, together
with good wound care in the groin are other important
factors for the prevention of recurrent infections. It would
seem wise for patients with mycotic aneurysms also to
receive prolonged antibiotic therapy even in the absence of
positive cultures.
The graft-stenosis rate in this series was 24%, treated
mainly by angioplasty (85%), but open procedures including
a profundoplasty and aortic vein patch angioplasty were
necessary in cases where angioplasty failed. This graft-
stenosis rate is greater than that reported by Beck et al.22
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Aortic reconstructions 
Time (months) 1 3 17 46
Number at Risk 21 17 15 11
KM Probability 0.86 0.76 0.71 0.65
Standard Error 0.076 0.093 0.100 0.110
Non-aortic reconstructions
Time (months) 2 14 29 44
Number at Risk 23 17 15 8
KM Probability 0.86 0.78 0.68 0.59
Standard Error 0.068 0.087 0.102 0.119
Figure 6 KaplaneMeier analysis of primary patency of aortic
(22 patients) and non-aortic procedures (24 patients) with
comparison by log rank test (Mantel method).
178 O. Ehsan, C.P. Gibbons(4.6%) and Daenens et al.19 (4%) but similar to that occur-
ring in other vein grafts. We do not have an explanation for
this discrepancy.
We have not found donor-limb swelling to be a signifi-
cant problem with FPV harvesting.29 Modrall et al. per-
formed prophylactic fasciotomy in 18% of cases,30 but
fasciotomy was not at all required in our series. Others have
provided compression hosiery but even those two cases
with marked swelling and bullae settled with elevation
alone in our series. Deep venous thrombosis in the donor-
limb and pulmonary embolism have been reported by
others,18 but to our knowledge, no patient developed deep
venous thrombosis in the donor limb in our series. No
routine investigations were performed to exclude deep-vein
thrombosis, but the interpretation of such investigations
would be difficult after deep-vein harvesting. The late
incidence of chronic venous insufficiency after deep-vein
harvesting, including oedema, skin changes and ulceration,
was 14.8% in one study29 but was rare in our patients.
There was no late treatment-related mortality following
FPV bypass, due to the almost complete elimination of graft
re-infection, confirming the results of Nevelsteen.19 In our
series, the two cases with unresolved infection occurring in
a residual prosthetic graft or in the adjacent artery were
successfully treated by further FPV grafts. However, Ali
et al. reported graft disruption secondary to uncontrolled
infection and failure of anastomotic healing in 2% ofpatients, with an associated mortality of 1%.33 In contrast
to these low re-infection rates with FPV, prosthetic
replacement is associated with a re-infection rate of
5e25%.4,31,32 The 5-year survival figures are also better for
FPV bypass (60e70% vs. 47e56%), although limb-salvage
and graft-patency rates are comparable.18,19,22,24,31,32 An
alternative approach for re-vascularisation in graft and
arterial infections is the use of arterial allografts: these
have the advantage of resistance to infection and good
long-term results have been reported by Vogt and
Kieffer,34,35 but others have reported a high incidence of
late aneurysm formation.36,37
It is of interest that the patients undergoing FPV aortic
reconstruction seem to have better long-term survival than
those undergoing iliac or femoral reconstruction. The
reason for this is not certain, but it may reflect the selec-
tion of a low-risk group of patients for aortic procedures.
The re-intervention rate for graft stenosis was similar for
aortic and ilio-femoral reconstructions.Conclusion
FPV is an excellent conduit for arterial reconstruction in the
presence of infection. Whilst the mainstay of treatment of
the infection is appropriate antibiotic therapy, removal
of any infected prosthetic graft and extensive debridement
of infected tissue, FPV bypass almost eliminates recurrent
infection, reduces the risk of late graft rupture and mini-
mises mortality.Conflict of Interest/Funding
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